Humana Inc.
HUMNYSEHealthcare● Active
$355.98
+$5.90(+1.69%)
Market Cap$42.7B
P/E Ratio—
52W High$356.01
52W Low$163.11
Humana Inc.（HUM）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · HUM · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $1.20B | $1.21B | $2.49B | $2.80B | $2.93B |
| Depreciation & Amort. | $0.82B | $0.97B | $0.92B | $0.84B | $0.71B |
| Stock-Based Comp. | $0.24B | $0.21B | $0.17B | $0.22B | $0.18B |
| Change in Working Capital | ($1.80B) | $0.15B | $0.08B | $0.53B | ($0.56B) |
| Net Cash from Operations | $0.92B | $2.97B | $3.98B | $4.59B | $2.26B |
| Investing Activities | |||||
| Capital Expenditure | ($0.55B) | ($0.57B) | ($1.00B) | ($1.14B) | ($1.34B) |
| Purchases of Investments | ($6.44B) | ($8.19B) | ($7.55B) | ($6.05B) | ($7.20B) |
| Sales of Investments | $9.42B | $6.36B | $5.09B | $3.80B | $6.14B |
| Net Cash from Investing | $2.27B | ($2.95B) | ($3.49B) | ($1.01B) | ($6.56B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.15B) | ($0.82B) | ($1.57B) | ($2.10B) | ($0.08B) |
| Dividends Paid | ($0.43B) | ($0.43B) | ($0.43B) | ($0.39B) | ($0.35B) |
| Debt Issued / Repaid | $0.53B | $0.22B | $0.42B | ($1.39B) | $3.76B |
| Net Cash from Financing | ($1.22B) | ($2.49B) | ($0.86B) | ($1.91B) | $3.02B |
| Free Cash Flow | |||||
| Free Cash Flow | $0.38B | $2.39B | $2.98B | $3.45B | $0.92B |
| FCF Margin %(computed) | 0.29% | 2.03% | 2.80% | 3.71% | 1.10% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Humana Inc.
关于Humana Inc.（HUM）现金流量表
Humana Inc. 2025财年经营活动现金流$0.92B，自由现金流$0.38B（FCF利润率0.29%），资本支出($0.55B)。
常见问题
HUM · 4 问Humana Inc. 2025财年自由现金流$0.38B，同比down84.3%。
HUM free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10